Phenotypic and genotypic detection of metallo-β-lactamases in A. baumanii isolates obtained from clinical samples in Shahrekord, southwest Iran.
Acinetobacter Infections
/ microbiology
Acinetobacter baumannii
/ enzymology
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ genetics
Cross Infection
/ microbiology
Drug Resistance, Multiple, Bacterial
Genotype
Imipenem
/ pharmacology
Iran
Meropenem
/ pharmacology
Metalloproteins
/ genetics
Microbial Sensitivity Tests
Phenotype
beta-Lactamases
/ genetics
Acinetobacter baumanii
Carbapenems
Iran
Metallo-beta-lactamase
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
18 Sep 2019
18 Sep 2019
Historique:
received:
12
07
2019
accepted:
11
09
2019
entrez:
20
9
2019
pubmed:
20
9
2019
medline:
11
2
2020
Statut:
epublish
Résumé
Acinetobacter baumanii is a pathogenic bacterium that is the cause of many nosocomial infections. This study aimed to determine metallo-β-lactamases (MBL) produced by the A. baumanii isolates obtained from clinical samples in Shahrekord, southwest Iran. A total of 100 A. baumanii were isolated from 250 clinical samples between June 2013 and June 2014. Then, the isolates were identified by biochemical tests, and MBL screening was conducted by the phenotypic tests modified Hodge, EDTA-disk synergy (EDS), combined disk (CD) and AmpC disc after antibiotic sensitivity test. Using PCR technique the bla genes were detected. Eighty-five (85%) isolates were resistant to meropenem and imipenem. Phenotypic tests showed that out of the 100 isolates, 46, 59, 50, 65 and 65 isolates were positive: AmpC disk, CD, EDS, Modified Hodge and E-test MBL respectively. Gene detection by PCR showed that 23 isolates carried the VIM-1 gene and only three isolates carried the IMP-1 gene. The prevalence of metallo-β-lactamases isolates containing A. baumanii is increasing. Furthermore, the coexistence of various carbapenemases is dominantly act as a major problem. Continuous monitoring of the infections related to these bacteria should be considered to plan an alternative and new therapeutic strategies.
Identifiants
pubmed: 31533853
doi: 10.1186/s13104-019-4636-y
pii: 10.1186/s13104-019-4636-y
pmc: PMC6751628
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
Metalloproteins
0
Imipenem
71OTZ9ZE0A
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Meropenem
FV9J3JU8B1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
597Subventions
Organisme : Shahrekord University of Medical Sciences
ID : 1392-01-74-1917
Références
J Microbiol. 2006 Aug;44(4):423-31
pubmed: 16953178
Clin Microbiol Rev. 2008 Jul;21(3):538-82
pubmed: 18625687
Antimicrob Agents Chemother. 2001 Sep;45(9):2598-603
pubmed: 11502535
Korean J Lab Med. 2008 Feb;28(1):16-23
pubmed: 18309251
Clin Microbiol Infect. 2002 Jun;8(6):321-31
pubmed: 12084099
Jpn J Infect Dis. 2011;64(1):69-71
pubmed: 21266761
Indian J Med Microbiol. 2011 Jul-Sep;29(3):269-74
pubmed: 21860108
Burns. 2012 Dec;38(8):1198-203
pubmed: 22579564
Food Chem Toxicol. 2012 Dec;50(12):4302-9
pubmed: 22982804
Clin Microbiol Infect. 2004 Aug;10(8):684-704
pubmed: 15301671
Diagn Microbiol Infect Dis. 2009 Feb;63(2):217-22
pubmed: 19070453
J Clin Microbiol. 2005 May;43(5):2241-5
pubmed: 15872249
Clin Infect Dis. 2008 Apr 15;46(8):1254-63
pubmed: 18444865
J Infect Chemother. 2012 Aug;18(4):522-8
pubmed: 22327516
Int J Antimicrob Agents. 2010 May;35(5):439-43
pubmed: 20106635
J Basic Microbiol. 2011 Oct;51(5):467-72
pubmed: 21656808
Clin Microbiol Infect. 2001 Feb;7(2):88-91
pubmed: 11298149
J Clin Microbiol. 2002 Aug;40(8):2755-9
pubmed: 12149325
J Microbiol Immunol Infect. 2011 Feb;44(1):39-44
pubmed: 21531351
Drug Resist Updat. 2011 Aug-Oct;14(4-5):236-50
pubmed: 21807550
Curr Opin Infect Dis. 2005 Aug;18(4):306-13
pubmed: 15985826
Nucleic Acids Res. 1991 Dec 25;19(24):6823-31
pubmed: 1762913
Scientifica (Cairo). 2014;2014:245162
pubmed: 25133013
Lancet Infect Dis. 2011 May;11(5):381-93
pubmed: 21530894
Indian J Med Microbiol. 2005 Apr;23(2):120-4
pubmed: 15928443
Acta Med Iran. 2010 May-Jun;48(3):178-84
pubmed: 21137655
Int J Antimicrob Agents. 2012 Nov;40(5):398-403
pubmed: 22890192
J Microbiol Methods. 2003 Sep;54(3):411-8
pubmed: 12842488